Skip to content

aTyr Pharma ATYR Increase (Decrease) in Prepaid Expense and Other Assets

Increase (Decrease) in Prepaid Expense and Other Assets at other companies

Design Therapeutics, Inc. logo
Design Therapeutics, Inc.DSGN
$287K-79.6%
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
$887K-26.2%
Vor Biopharma logo
Vor BiopharmaVOR
$6.36M+2,653%
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
$679K+18.1%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$3.79M-71.2%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
-$7.84M-30.8%

Other financials

Income statement

See full
Revenue-
Operating income-$11.4M+27.5%
Net income-$10.8M+27.5%
EPS (diluted)-$0.11+35.3%

Balance sheet

See full
Cash & equivalents$10.0M-3.4%
Total debt$12.3M-9.2%
Total equity$57.9M-22.8%
Total assets$79.7M-18.1%

Cash flow

See full
Operating cash flow-$12.5M+18.8%
CapEx$138.0K
Free cash flow-$12.7M+17.9%

Valuation

See full
Market cap$54.88M-88.2%
Enterprise value$57.17M
P/S288.8×

Profitability

See full
Operating margin-40,856.3%+28,833pp
Net margin-39,009.5%+29,653pp
FCF margin-32,664.7%+4,018pp

Returns & leverage

See full
Return on equity-105.3%+50.6pp
Debt / equity0.2×0.0×
Current ratio5.8×-2.0×

Where this comes from

Reported directly by aTyr Pharma in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: aTyr Pharma’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about aTyr Pharma's increase (decrease) in prepaid expense and other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is aTyr Pharma's increase (decrease) in prepaid expense and other assets?
aTyr Pharma (ATYR) reported increase (decrease) in prepaid expense and other assets of -$91K in Q1 2026.
How has aTyr Pharma's increase (decrease) in prepaid expense and other assets changed year-over-year?
aTyr Pharma's increase (decrease) in prepaid expense and other assets increased by 95.8% year-over-year, from -$2.16M to -$91K.
What is the long-term trend for aTyr Pharma's increase (decrease) in prepaid expense and other assets?
Over 2 years (2021 to 2025), aTyr Pharma's increase (decrease) in prepaid expense and other assets has grown at a 54.4% compound annual growth rate (CAGR), from $3.38M to -$8.05M.
What does increase (decrease) in prepaid expense and other assets mean?
This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.